British American Tobacco stock trades 0.5% below Xetra close
Published on 11/18/2026 at 17:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for BAT investors
- The stock was 4.31% below its November 13 level by Wednesday afternoon.
- JPMorgan expects like-for-like growth of 3% to 5% in 2027, according to Investing.com.
- BAT's December pre-close trading update is the next operating catalyst.
British American Tobacco stock traded at 53.46 euros on Lang & Schwarz at 17:04 CET on Wednesday, November 18, 2026, 0.52% below the Xetra close of 53.74 euros on Tuesday, November 17. The quote was 4.31% below the 55.87 euros reported for BAT on Friday, November 13.
Price move since November 13
The comparison with November 13 shows a materially lower level for the London-listed tobacco group over the intervening sessions. The move is separate from Wednesday's intraday comparison with the previous Xetra close.
JPMorgan's growth thesis
On November 10, Investing.com reported that JPMorgan had reinstated coverage with an Overweight rating and a 5,300-pence price target. The bank projected like-for-like growth of 3.9% in 2027 and adjusted earnings per share of 389 pence, citing market-share gains in U.S. vapor and nicotine pouches.
JPMorgan also linked its outlook to easing pressure in Asia Pacific, the Middle East and Africa and improved recent trends in the U.S. cigarette market. The analyst view is an external assessment rather than company guidance.
Next catalyst for investors
BAT's December pre-close trading update is the next scheduled operating test for whether momentum in newer nicotine categories is translating into the growth profile outlined by JPMorgan. Investors will also weigh regional demand, regulation and execution in the U.S. market.
British American Tobacco at a glance
- Company: British American Tobacco p.l.c.
- ISIN: GB0002875804
- London ticker: BATS:LN
- Lang & Schwarz quote: 53.46 euros at 17:04 CET on November 18, 2026
- Xetra close: 53.74 euros on November 17, 2026
- Analyst rating: JPMorgan Overweight
- Price target: 5,300 pence
Investors can follow Current market reports for developments across European equities.
More news and analyses on British American Tobacco stock.
